Russia claims new coronavirus vaccine is 100% successful as all volunteers have immunity


All participants of a clinical trial developed an immunity to SARS-CoV-2, the Russian government claims, although there are concerns the vaccine was rushed through safety tests


Russia has claimed its experimental new coronavirus vaccine has had a 100% success rate in a clinical trial.


Every participant in the recent trial who received the vaccine, developed by the Russian Defence Ministry and the Gamaleya National Centre for Research on Epidemiology and Microbiology, have reportedly shown signs of immunity to SARS-CoV-2.


The trial began 42 days ago when volunteers, understood to be scientific researchers, were injected with the vaccine at the Burdenko military military hospital in Moscow.


Yesterday they returned to the institution to undergo a thorough examination of whether their immune systems had produced antibodies, indicating resistance to coronavirus.




All volunteers who received the vaccine developed immunity, the Russian government claims (Image: Russian Defense Ministry)

All participants were found to have developed some level of immunity, causing the government to hail the vaccine a success.


"The results of the reviews have clearly demonstrated the existence of an evident immune response obtained as a result of vaccination," the Russian Ministry of Defence announced.


They claim none of the volunteers experienced any negative side effects or complications. The laboratory which developed the vaccine is now seeking regulatory approval before it can be used on the wider public.




Nations around the world are battling to be the first to develop a coronavirus vaccine (Image: NurPhoto/PA Images)

The Russian government claims it is months ahead of its global rivals in the race to develop an effective vaccine against Covid-19.


With the apparent success of its clinical trial, the country is set to begin three large-scale phase three trials this month to further test the vaccine's efficacy.


Russia intends to begin producing the vaccine in September and start a national campaign of mass immunisation from October.




Russia has been criticised for rushing its vaccine candidates through safety testing (Image: Getty Images/iStockphoto)

Members of certain groups, such as doctors and teachers, will receive the vaccine first.


Health Minister Mikhail Murashko also said a second vaccine, developed by the Vktor State Center for Research in Virology and Biotechnology in Novosibirsk, is currently undergoing clinical trials.


However, there has been international criticism of how Russia has conducted its trials, with some saying the vaccines were rushed through safety testing.


Last week Prime Minister Mikhail Mishustin announced there were 17 different scientific organisations across Russia working on more than 25 vaccine candidates.


However the World Health Organisation (WHO) does not include any second or third phase Russian vaccines in its official list of 26 candidates currently undergoing clinical trials around the world.


So far Russia has recorded more than 861,000 cases of coronavirus and its death toll stands at 14,351.